Abstract | OBJECTIVE: METHODS: RESULTS: All patients enrolled in group A (108 cases) and group B (103 cases) went through the study. Between the two groups, there were no differences in the mean time of partial and complete pain relief rates every day. The partial pain relief rate on day one was higher in group A (56%) than that in group B (33%, P < 0.05). On day seven, acid regurgitation relief rate was higher in group A than that in group B (100% and 83%, respectively, P < 0.05). No significant difference in the rate of partial pain relief and acid regurgitation on the other days of the treatment. The relief rate of abdominal bloatness and belching everyday in the two groups were similar. No adverse events took place in both groups. CONCLUSIONS:
|
Authors | Sanren Lin, Multicenter Clinic Trial Group of Rabeprazol |
Journal | Zhonghua nei ke za zhi
(Zhonghua Nei Ke Za Zhi)
Vol. 41
Issue 9
Pg. 589-91
(Sep 2002)
ISSN: 0578-1426 [Print] China |
PMID | 12421488
(Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Benzimidazoles
- Rabeprazole
- Omeprazole
|
Topics |
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Adolescent
- Adult
- Aged
- Benzimidazoles
(therapeutic use)
- Double-Blind Method
- Duodenal Ulcer
(drug therapy)
- Humans
- Middle Aged
- Omeprazole
(therapeutic use)
- Rabeprazole
|